| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 8,710 | 2,991 | 989 | | Selling General and Administrative | 2,184 | 2,036 | 1,913 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (10,894) | (5,027) | (2,902) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 329 | 888 | 173 | | Earnings Before Interest And Taxes | (10,565) | (4,139) | (2,729) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (10,565) | (4,139) | (2,729) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,565) | (4,139) | (2,729) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (10,565) | (4,139) | (2,729) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,565) | ($4,139) | ($2,729) |
|
0.01% Nasdaq 0.00%
Income Statement
